Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human

Human Molecular Genetics
David MonkG E Moore

Abstract

Genomic imprinting is limited to a subset of genes that play critical roles in fetal growth, development and behaviour. One of the most studied imprinted genes encodes insulin-like growth factor 2, and aberrant imprinting and DNA methylation of this gene is associated with the growth disorders Beckwith-Wiedemann and Silver-Russell syndromes and many human cancers. Specific isoforms of this gene have been shown to be essential for normal placental function, as mice carrying paternal null alleles for the Igf2-P0 transcript are growth restricted at birth. We report here the identification of three novel human transcripts from the IGF2 locus. One is equivalent to the mouse Igf2-P0 transcript, whereas the two others (INSIGF long and short) originate from the upstream INS gene that alternatively splices to downstream IGF2 exons. In order to elucidate the molecular mechanisms involved in the complex imprinting of these novel IGF2 transcripts, both the allele-specific expression and methylation for all the IGF2 promoters including P0 and the INSIGF transcripts were analysed in human tissues. Similar to the mouse, the human IGF2-P0 transcript is paternally expressed; however, its expression is not limited to placenta. This expression co...Continue Reading

References

Oct 1, 1991·Molecular and Cellular Endocrinology·M A van DijkJ S Sussenbach
Feb 22, 1991·Cell·T M DeChiaraA Efstratiadis
Feb 1, 1997·Nature Genetics·A D LightenG E Moore
Apr 7, 1997·Biochemical and Biophysical Research Communications·H K WuR Weksberg
Jun 15, 1997·Nucleic Acids Research·Z Xiong, P W Laird
Sep 1, 1997·Human Molecular Genetics·J A JoyceP N Schofield
Sep 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·T FornéW Reik
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·T MooreW Reik
May 14, 1999·Current Opinion in Genetics & Development·C I Brannan, M S Bartolomei
Jan 9, 2001·Diabetes·G E MooreS T Bennett
Jul 4, 2001·The EMBO Journal·S EdenH Cedar
Mar 15, 2003·Science·Hengmi CuiAndrew P Feinberg
Sep 18, 2003·Placenta·Abigail L Fowden
May 20, 2004·Proceedings of the National Academy of Sciences of the United States of America·C P SibleyM Constância

❮ Previous
Next ❯

Citations

Dec 21, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·S ApostolidouG E Moore
Oct 31, 2012·Biochemical Genetics·Carolina Duart-Garcia, Martin H Braunschweig
Jul 9, 2009·European Journal of Human Genetics : EJHG·Céline Chalas BoissonnasHélène Jammes
Jun 24, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·N Y SourenM P Zeegers
Aug 8, 2013·Nature Communications·Mikael Allan MikaelssonTrevor Humby
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Hélène BiernePascale Cossart
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Vesco Mutskov, Gary Felsenfeld
Mar 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Julian C Lui, Jeffrey Baron
Jun 17, 2010·Briefings in Functional Genomics·David Monk
Aug 7, 2009·Human Molecular Genetics·Elmar W TobiBastiaan T Heijmans
Nov 20, 2012·Nucleic Acids Research·Kristian A GrayElspeth A Bruford
Nov 6, 2010·Sarcoma·Vivek Subbiah, Pete Anderson
Aug 30, 2012·Epigenetics & Chromatin·Jessica M StringerMarilyn B Renfree
Jul 10, 2010·PLoS Genetics·Jennifer M Frost, Gudrun E Moore
Aug 1, 2012·PloS One·Jessica M StringerMarilyn B Renfree
Sep 21, 2013·International Journal of Molecular Sciences·Amaresh C PandaKotb Abdelmohsen
Feb 2, 2012·Molecular Medicine Reports·Ourania KoukouraDemetrios A Spandidos
Jun 18, 2014·BMC Medical Genetics·Rinki MurphyUNKNOWN Auckland Birthweight Collaborative Study Group
Mar 7, 2014·Heredity·J M StringerM B Renfree
Jun 11, 2008·Human Molecular Genetics·Yoko ItoAdele Murrell
Feb 24, 2010·Expert Opinion on Biological Therapy·Antonio Gualberto
Jul 16, 2010·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·S RodriguezI N M Day
Apr 21, 2010·Hormones and Behavior·Eleni KopsidaWilliam Davies
Apr 18, 2014·Cell Proliferation·M NordinA Ward
Oct 3, 2015·American Journal of Obstetrics and Gynecology·Vania JanuarRichard Saffery
Oct 9, 2015·International Journal of Endocrinology·Vinodh Kumar RadhakrishnanDaisy D De León
Jun 16, 2015·Scandinavian Journal of Immunology·N KanatsunaÅ Lernmark
Nov 22, 2011·International Journal of Epidemiology·Rudolf P TalensUNKNOWN PROSPER Group
Jul 30, 2015·BMC Molecular Biology·Rasmus WernerssonOle Dragsbæk Madsen
Feb 24, 2015·Cytokine & Growth Factor Reviews·Jurriaan Brouwer-Visser, Gloria S Huang
Oct 12, 2010·Epigenetics : Official Journal of the DNA Methylation Society·Elmar W TobiP Eline Slagboom

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beckwith-Wiedemann syndrome

Beckwith-Wiedemann syndrome is an imprinting disorder characterized by overgrowth, congenital malformations and predisposition to tumors. Discover the latest research on Beckwith-Wiedemann Syndrome here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.